N. B. Atkin and M. C. Baker, Chromosome 7q deletions: observations on 13 malignant tumors, Cancer Genet Cytogenet, vol.67, pp.123-125, 1993.
DOI : 10.1016/0165-4608(93)90164-h

H. S. Chand, X. Du, D. Ma, H. D. Inzunza, S. Kamei et al., The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice, Blood, vol.103, pp.1069-1077, 2004.

G. Cox, W. P. Steward, O. Byrne, and K. J. , The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer, Thorax, vol.54, pp.169-179, 1999.

M. Egeblad and Z. Werb, New functions for the matrix metalloproteinases in cancer progression, Nat Rev Cancer, vol.2, pp.161-174, 2002.

M. Esteller, S. R. Hamilton, P. C. Burger, S. B. Baylin, and J. G. Herman, Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia, Cancer Res, vol.59, pp.793-797, 1999.

R. Etzioni, N. Urban, S. Ramsey, M. Mcintosh, S. Schwartz et al., The case for early detection, Nat Rev Cancer, vol.3, pp.243-252, 2003.

M. F. Fraga and M. Esteller, DNA methylation: a profile of methods and applications, Biotechniques, vol.33, pp.636-649, 2002.

J. G. Herman and S. B. Baylin, Gene silencing in cancer in association with promoter hypermethylation, N Engl J Med, vol.349, pp.2042-2054, 2003.

F. Hube, P. Reverdiau, S. Iochmann, C. Cherpi-antar, and Y. Gruel, Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line, Thromb Res, vol.109, pp.207-215, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02127781

F. Hube, P. Reverdiau, S. Iochmann, J. Rollin, C. Cherpi-antar et al., Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells, Biol Chem, vol.384, pp.1029-1034, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02127398

F. Hube, P. Reverdiau, S. Iochmann, S. Trassard, G. Thibault et al., Demonstration of a tissue factor pathway inhibitor 2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas, Biol Reprod, vol.68, pp.1888-1894, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02127745

S. Iochmann, P. Reverdiau-moalic, S. Beaujean, E. Rideau, Y. Lebranchu et al., Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction, Thromb Res, vol.94, pp.165-173, 1999.

S. Iochmann, P. Reverdiau-moalic, F. Hube, P. Bardos, and Y. Gruel, Demonstration of inducible TFPI-2 mRNA synthesis in BeWo and JEG-3 trophoblast cells using a competitive RT-PCR, Thromb Res, vol.105, pp.217-223, 2002.
URL : https://hal.archives-ouvertes.fr/hal-02127753

H. Izumi, C. Takahashi, J. Oh, and M. Noda, Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes, FEBS Lett, vol.481, pp.31-36, 2000.

C. Kast, M. Wang, and M. Whiteway, The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter, J Biol Chem, vol.278, pp.6787-6794, 2003.

S. D. Konduri, K. S. Srivenugopal, N. Yanamandra, D. H. Dinh, W. C. Olivero et al., Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells, Oncogene, vol.22, pp.4509-4516, 2003.

S. D. Konduri, A. Tasiou, N. Chandrasekar, G. L. Nicolson, and J. S. Rao, Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion, Clin Exp Metast, vol.18, pp.303-308, 2000.

S. D. Konduri, A. Tasiou, N. Chandrasekar, and J. S. Rao, Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro, Int J Oncol, vol.18, pp.127-131, 2001.

S. S. Lakka, S. D. Konduri, S. Mohanam, G. L. Nicolson, and J. S. Rao, In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2, Clin Exp Metast, vol.18, pp.239-244, 2000.

Y. Miyagi, H. Yasumitsu, T. Eki, S. Miyata, N. Kkawa et al., Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis, Genomics, vol.35, pp.267-268, 1996.

C. F. Mountain, Revisions in the International System for staging lung cancer, Chest, vol.111, pp.1710-1717, 1997.

J. Pei, B. R. Balsara, W. Li, S. Litwin, E. Gabrielson et al., Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas, Genes Chromosomes Cancer, vol.31, pp.282-287, 2001.

C. N. Rao, S. S. Lakka, Y. Kin, S. D. Konduri, G. N. Fuller et al., Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas, Clin Cancer Res, vol.7, pp.570-576, 2001.

C. N. Rao, S. Mohanam, A. Puppala, and J. S. Rao, Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrixassociated serine protease inhibitor, Biochem Biophys Res Commun, vol.255, pp.94-98, 1999.

C. N. Rao, P. Reddy, Y. Liu, E. O'toole, D. Reeder et al., Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2, Arch Biochem Biophys, vol.335, pp.82-92, 1996.

C. N. Rao, P. Reddy, D. J. Reeder, Y. Liu, S. M. Stack et al., Prokaryotic expression, purification, and reconstitution of biological activities (antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2, Biochem Biophys Res Commun, vol.276, pp.1286-1294, 2000.

C. N. Rao, T. Segawa, J. R. Navari, L. Xu, S. Srivastava et al., Methylation of TFPI-2 gene is not the sole cause of its silencing, Int J Oncol, vol.22, pp.843-848, 2003.

X. Tang, F. R. Khuri, J. J. Lee, B. L. Kemp, D. Liu et al., Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer, J Natl Cancer Inst, vol.92, pp.1511-1516, 2000.

A. Tasiou, S. D. Konduri, N. Yanamandra, D. H. Dinh, W. C. Olivero et al., A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas, Int J Oncol, vol.19, pp.591-597, 2001.

W. D. Travis, T. V. Colby, B. Corrin, Y. Shimosato, and E. Brambilla, World Health Organization Classification of Lung and Pleural Tumors, 1999.

B. Tycko, Epigenetic gene silencing in cancer, J Clin Invest, vol.105, pp.401-407, 2000.

K. K. Wang, N. Liu, N. Radulovich, D. A. Wigle, M. R. Johnston et al., Novel candidate tumor marker genes for lung adenocarcinoma, Oncogene, vol.21, pp.7598-7604, 2002.

M. Z. Wojtukiewicz, E. Sierko, L. Zimnoch, L. Kozlowski, and W. Kisiel, Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue, Thromb Haemost, vol.90, pp.140-146, 2003.

N. Yanagawa, G. Tamura, H. Oizumi, N. Takahashi, Y. Shimazaki et al., Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers, Cancer Sci, vol.94, pp.589-592, 2003.

S. Zochbauer-muller, A. F. Gazdar, and J. D. Minna, Molecular pathogenesis of lung cancer, Annu Rev Physiol, vol.64, pp.681-708, 2002.